UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long–Evans Tokushima Fatty rats
- 149 Downloads
Uridine 5′-diphosphate (UDP) plays an important role in controlling vascular tone; however, UDP-mediated response in metabolic syndromes, including obesity and type 2 diabetes in females, remains unclear. In this study, we investigated UDP-mediated response in the aorta of female obese Otsuka Long–Evans Tokushima Fatty (OLETF) rats and control Long–Evans Tokushima Otsuka (LETO) rats. In OLETF rat aortas precontracted by phenylephrine (PE) (vs. LETO), (1) UDP-induced relaxation was increased, whereas acetylcholine (ACh)-induced relaxation was decreased; (2) no UDP- or ACh-induced relaxations were observed in endothelial denudation, whereas UDP-induced small contraction was observed; and (3) NG-nitro-L-arginine [L-NNA, a nitric oxide (NO) synthase inhibitor] eliminated UDP-induced relaxation and small contraction, whereas caused contrasting responses by ACh, including slight relaxations (LETO) and contractions (OLETF). Indomethacin, a cyclooxygenase inhibitor, eliminated the difference in UDP- and ACh-induced relaxations between the groups by increased UDP-induced relaxation in the LETO group and increased ACh-induced relaxation in the OLETF group. MRS2578, a P2Y6 receptor antagonist, eliminated the difference in UDP-induced relaxations between the groups by decreasing UDP-induced relaxation in the OLETF group. MRS2578 had no effect on UDP-induced contraction in endothelium-denuded aortas. Therefore, these findings demonstrate opposite trends of relaxations by UDP and ACh in OLETF and LETO rat aortas. These differences may be attributed to the imbalance between NO and vasoconstrictor prostanoids upon stimulations. Increased UDP-induced relaxation in OLETF rat aorta may be caused by the activation of endothelial MRS2578-sensitive P2Y6 receptor.
KeywordsObese Female P2Y6 Relaxation UDP
Endothelium-derived contracting factor
Endothelium-derived relaxing factor
Long-Evans Tokushima Otsuka
Nitric oxide synthase
Otsuka Long-Evans Tokushima Fatty
We thank T. Kamioka, S. Oshima, Y. Ohta, S. Ohashi, A. Ozeki, S. Takeno, M. Tani, and M. Tamura for technical assistance. This study was supported in part by JSPS KAKENHI Grant Numbers JP17K08318 and JP15K07975 and by the Suzuken Memorial Foundation (Japan). The authors would like to thank Enago (www.enago.jp) for the English language review.
Compliance with ethical standards
Conflicts of interest
Shota Kobayashi declares that he has no conflict of interest.
Takayuki Matsumoto declares that he has no conflict of interest.
Makoto Ando declares that he has no conflict of interest.
Maika Iguchi declares that he/she has no conflict of interest.
Shun Watanabe declares that he has no conflict of interest.
Kumiko Taguchi declares that she has no conflict of interest.
Tsuneo Kobayashi declares that he has no conflict of interest.
This study was approved by the Hoshi University Animal Care and Use Committee, and all studies were conducted in accordance with the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health, and the Guide for the Care and Use of Laboratory Animals adopted by the Committee on the Care and Use of Laboratory Animals of Hoshi University (accredited by the Ministry of Education, Culture, Sports, Science, and Technology, Japan).
- 4.Zhang Z, Wang Z, Ren H, Yue M, Huang K, Gu H, Liu M, Du B, Qian M (2011) P2Y(6) agonist uridine 5′-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocyte/macrophage recruitment. J Immunol 186:5376–5387. https://doi.org/10.4049/jimmunol.1002946 CrossRefPubMedGoogle Scholar
- 5.Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinohl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A (2014) P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 34:2237–2245. https://doi.org/10.1161/ATVBAHA.114.303585 CrossRefPubMedGoogle Scholar
- 9.Vonend O, Stegbauer J, Sojka J, Habbel S, Quack I, Robaye B, Boeynaems JM, Rumb LC (2005) Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney. Br J Pharmacol 145:66–74CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Kauffenstein G, Tamareille S, Prunier F, Roy C, Ayer A, Toutain B, Billaud M, Isakson BE, Grimaud L, Loufrani L, Rousseau P, Abraham P, Procaccio V, Monyer H, de Wit C, Boeynaems JM, Robaye B, Kwak BR, Henrion D (2016) Central role of P2Y6 UDP receptor in arteriolar myogenic tone. Arterioscler Thromb Vasc Biol 36:1598–1606. https://doi.org/10.1161/ATVBAHA.116.307739 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Haanes KA, Spray S, Syberg S, Jorgensen NR, Robaye B, Boeynaems JM, Edvinsson L (2016) New insight on pyrimidine signalling within the arterial vasculature—different roles for P2Y2 and P2Y6 receptors in large and small coronary arteries of the mouse. J Mol Coll Cardiol 93:1–11. https://doi.org/10.1016/j.yjmcc.2016.01.025 CrossRefGoogle Scholar
- 13.Matsumoto T, Tostes RC, Webb RC (2012) Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. Pharmacol Res 65:81–90. https://doi.org/10.1016/j.phrs.2011.09.005 CrossRefPubMedGoogle Scholar
- 21.Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K (2008) Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 295:H1165–H1176. https://doi.org/10.1152/ajpheart.00486.2008. CrossRefPubMedGoogle Scholar
- 22.Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K (2009) Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rat at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329:324–334. https://doi.org/10.1124/jpet.108.148718 CrossRefPubMedGoogle Scholar
- 24.Matsumoto T, Watanabe S, Ando M, Yamada K, Iguchi M, Taguchi K, Kobayashi T (2016) Diabetes and age-related differences in vascular function of renal artery: possible involvement of endoplasmic reticulum stress. Rejuvenation Res 19:41–52. https://doi.org/10.1089/rej.2015.1662 CrossRefPubMedGoogle Scholar
- 26.Amon L, Hazut N, Tabachinik T, Weller A, Koren L (2016) Maternal testosterone and reproductive outcome in a rat model of obesity. Theriogenology 86:1042–1047. https://doi.org/10.1016/j.theriogenology.2016.03.033 CrossRefGoogle Scholar
- 28.Matsumoto T, Kobayashi S, Ando M, Watanabe S, Iguchi M, Taguchi K, Kobayashi T (2017) Impaired endothelium-derived hyperpolarization-type relaxation in superior mesenteric arteries isolated from female Otsuka Long-Evans Tokushima Fatty rats. Eur J Pharmacol 807:151–158. https://doi.org/10.1016/j.ejphar.2017.03.062 CrossRefPubMedGoogle Scholar
- 29.McCarthy CG, Wenceslau CF, Goulopoulou S, Ogbi S, Matsumoto T, Webb RC (2016) Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats. Pharmacol Res 113:384–394. https://doi.org/10.1016/j.phrs.2016.09.008. CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T (2015) Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol 172:3980–4001. https://doi.org/10.1111/bph.13205 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T (2011) Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am J Physiol Heart Circ Physiol 301:H1850–H1861. https://doi.org/10.1152/ajpheart.00502.2011. CrossRefPubMedGoogle Scholar
- 36.Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25:4615–4627. https://doi.org/10.1038/sj.emboj.7601341 CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Nishimura A, Sunggip C, Tozaki-Saitoh H, Shimauchi T, Numaga-Tomita T, Hirano K, Ide T, Boeynaems JM, Kurose H, Tsuda M, Robaye B, Inoue K, Nishida M (2016) Purinergic P2Y6 receptor heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension. Sci Signal 9:ra7. https://doi.org/10.1126/scisignal.aac9187 CrossRefPubMedGoogle Scholar